rethinkPeptides Search
Menu
Research citation

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Frontiers in pharmacology, 9, 576

Citation

Shi, Fang-Hong; Li, Hao; Cui, Min; Zhang, Zai-Li; Gu, Zhi-Chun; Liu, Xiao-Yan. (2018). Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Frontiers in pharmacology, 9, 576. https://doi.org/10.3389/fphar.2018.00576